IngMar Medical
Private Company
Funding information not available
Overview
IngMar Medical is a pioneering, privately-held company in the medical simulation sector, focused exclusively on respiratory and critical care training. Its core technology is the ASL 5000 Breathing Simulator, a sophisticated platform that accurately mimics a wide range of lung pathologies and is considered an industry standard. The company serves three primary markets: clinical education, biomedical research & development, and device testing, with a recent strategic push to expand accessibility through more affordable products like the Aurora manikin. With nearly 30 years of operation, IngMar has established a strong reputation for technical excellence, deep customer support, and a validated product portfolio that addresses a critical training gap in healthcare.
Technology Platform
Proprietary breathing simulation technology centered on the ASL 5000, a computer-controlled piston-based system that accurately replicates human lung mechanics (compliance, resistance) and pathologies. It includes RespiSim software for control and analysis, and newer ISL (Internal Smart Lung) technology for integrated manikin-based systems.
Opportunities
Risk Factors
Competitive Landscape
IngMar Medical occupies a unique, leadership position in high-fidelity respiratory-specific simulation. While it competes with large full-body patient simulator companies (e.g., Laerdal, CAE) that may offer basic lung mechanics, its ASL 5000 platform is considered best-in-class for advanced pulmonary physiology. Its main competition comes from alternative training methods and in-house solutions, rather than direct product equivalents.